Objectif
Assuming an annual birth rate of 10.25 births/1,000 population approximately 25,000 Extremely Low Gestational Age Newborns are born every year in the EU. Conservative figures estimate that approximately half of all these babies will develop low blood pressure and require treatment. However, no uniform criteria exist to define hypotension and the evidence to support our current management strategies is limited. Many of these interventions have been derived from adult literature and have not been validated in the newborn. Dopamine remains the most common inotrope used despite little evidence that it improves outcome. Hypotension is not only associated with mortality of preterm infants but is also associated with brain injury and impaired neurosensory development in ELGAN survivors. Preterm brain injury has far reaching implications for the child, parents, family, health service and society at large. It is therefore essential that we now design and perform the appropriate trials to determine whether the infusion of inotropic agents is associated with improved outcome. We have assembled a consortium with expertise in key areas of neonatal cardiology, neonatology, neurophysiology, basic science and pharmacology with the intention of answering these questions. The objectives of the group are as follows:
1. To perform a multinational, randomized controlled trial to evaluate whether a more restricted approach to the diagnosis and management of hypotension compared to a standard approach, with dopamine as a first line inotrope, affects survival without significant brain injury at 36 weeks gestational age in infants born less than 28 weeks gestation and affects survival without neurodevelopmental disability at 2 years corrected age
2. To perform pharmacokinetic and pharmcodynamic studies of dopamine
3. To develop and adapt a formulation of dopamine suitable for newborns in order to apply for a Paediatric Use Marketing Authorization
Champ scientifique
Appel à propositions
FP7-HEALTH-2010-single-stage
Voir d’autres projets de cet appel
Régime de financement
CP-FP - Small or medium-scale focused research projectCoordinateur
T12 YN60 Cork
Irlande
Voir sur la carte
Participants (16)
3000 Leuven
Voir sur la carte
116 36 Praha 1
Voir sur la carte
H3T 1C5 MONTREAL QUEBEC
Voir sur la carte
4 Dublin
Voir sur la carte
Dublin 8 Dublin
Voir sur la carte
69007 LYON
Voir sur la carte
WC1E 6BT LONDON
Voir sur la carte
D18 Dublin
Voir sur la carte
Participation terminée
80333 Muenchen
Voir sur la carte
75654 Paris
Voir sur la carte
T5J 4P6 EDMONTON ALBERTA
Voir sur la carte
2 Dublin
Voir sur la carte
2650 Edegem
Voir sur la carte
708 52 Ostrava Poruba
Voir sur la carte
76275 Zlin
Voir sur la carte
75008 Paris
Voir sur la carte